The clinical spectrum of sporadic and familial forms of frontotemporal dementia

Journal of Neurochemistry

Volumn , Issue , 2016, Pages 6-31

  Woollacott, Ione O C ^a   Rohrer, Jonathan D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

amyotrophic lateral sclerosis; C9ORF72; frontotemporal dementia; progranulin; tau

Indexed keywords

CHARGED MULTIVESICULAR BODY PROTEIN 2B; CHROMOSOME 9 OPEN READING FRAME 72 PROTEIN; CHROMOSOME PROTEIN; PROGRANULIN; SEQUESTOSOME 1 PROTEIN; TANK BINDING KINASE 1 PROTEIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UBIQUILIN 2 PROTEIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

C9ORF72 GENE; CHMP2B GENE; CLINICAL FEATURE; COGNITION; COMPREHENSION; CORTICOBASAL DEGENERATION; EARLY DIAGNOSIS; FAMILIAL FRONTOTEMPORAL DEMENTIA; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENE; HUMAN; LANGUAGE; LOGOPENIC VARIANT PRIMARY PROGRESSIVE APHASIA; MOTOR NEURON DISEASE; NON FLUENT VARIANT PRIMARY PROGRESSIVE APHASIA; PARKINSONISM; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; READING; REVIEW; SEMANTIC VARIANT PRIMARY PROGRESSIVE APHASIA; SPORADIC FRONTOTEMPORAL DEMENTIA; SQSTM1 GENE; TBK1 GENE; UBQLN2 GENE; WRITING;

EID: 84981263293     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13654     Document Type: Review

References (292)

1. Ahmed S., de Jager C. A., Haigh A. M. and Garrard P. (2012) Logopenic aphasia in Alzheimer's disease: clinical variant or clinical feature? J. Neurol. Neurosurg. Psychiatry 83, 1056–1062.
2. Ahmed R. M., Iodice V., Daveson N., Kiernan M. C., Piguet O. and Hodges J. R. (2015) Autonomic dysregulation in frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 86, 1048–1049.
3. Alzheimer A. (1911) Über eigenartige Krankheitsfälle des späteren Alters. Zeitschrift für die gesamte Neurologie und Psychiatrie 4, 356–385.
4. Arighi A., Fumagalli G. G., Jacini F. et al. (2012) Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J. Alzheimers Dis. 31, 447–452.
5. Assal F., Laganaro M., Remund C. D. and Ragno Paquier C. (2012) Progressive crossed-apraxia of speech as a first manifestation of a probable corticobasal degeneration. Behav. Neurol. 25, 285–289.
6. Baborie A., Griffiths T. D., Jaros E. et al. (2011) Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol. 121, 365–371.
7. Baker M., Mackenzie I. R., Pickering-Brown S. M. et al. (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916–919.
8. Balasa M., Gelpi E., Martin I. et al. (2015) Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort. Neuropathol. Appl. Neurobiol. 41, 882–892.
9. Bannwarth S., Ait-El-Mkadem S., Chaussenot A. et al. (2014) A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137, 2329–2345.
10. Barquero S., Gomez-Tortosa E., Baron M., Rabano A., Munoz D. G. and Jimenez-Escrig A. (2010) Amusia as an early manifestation of frontotemporal dementia caused by a novel progranulin mutation. J. Neurol. 257, 475–477.
11. Bateman R. J., Xiong C., Benzinger T. L. et al. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795–804.
12. Bathgate D., Snowden J. S., Varma A., Blackshaw A. and Neary D. (2001) Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol. Scand. 103, 367–378.
13. Baxter D. M. and Warrington E. K. (1987) Transcoding sound to spelling: single or multiple sound unit correspondence? Cortex 23, 11–28.
14. Beck J., Rohrer J. D., Campbell T. et al. (2008) A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 131, 706–720.
15. Beck J., Poulter M., Hensman D. et al. (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am. J. Hum. Genet. 92, 345–353.
16. Benajiba L., Le Ber I., Camuzat A. et al. (2009) TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 65, 470–473.
17. Benatar M., Wuu J., Fernandez C., Weihl C. C., Katzen H., Steele J., Oskarsson B. and Taylor J. P. (2013) Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology 80, 1874–1880.
18. Benitez B. A., Cooper B., Pastor P., Jin S. C., Lorenzo E., Cervantes S. and Cruchaga C. (2013) TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol. Aging 34, 1711e1715-e1717.
19. Benussi A., Padovani A. and Borroni B. (2015) Phenotypic heterogeneity of monogenic frontotemporal dementia. Front. Aging Neurosci. 7, 171.
20. Bessi V., Bagnoli S., Nacmias B., Tedde A., Sorbi S. and Bracco L. (2010) Semantic dementia associated with mutation V363I in the tau gene. J. Neurol. Sci. 296, 112–114.
21. Blair I. P., Williams K. L., Warraich S. T. et al. (2010) FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry 81, 639–645.
22. van Blitterswijk M., Baker M. C., DeJesus-Hernandez M. et al. (2013) C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology 81, 1332–1341.
23. van Blitterswijk M., Mullen B., Nicholson A. M. et al. (2014) TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol. 127, 397–406.
24. Boeve B. F., Boylan K. B., Graff-Radford N. R. et al. (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135, 765–783.
25. Borroni B., Bonvicini C., Alberici A. et al. (2009) Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat. 30, E974–E983.
26. Borroni B., Ferrari F., Galimberti D. et al. (2014) Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol. Aging 35, 934, e937-e910.
27. Bozeat S., Lambon Ralph M. A., Patterson K., Garrard P. and Hodges J. R. (2000) Non-verbal semantic impairment in semantic dementia. Neuropsychologia 38, 1207–1215.
28. Brambati S. M., Rankin K. P., Narvid J., Seeley W. W., Dean D., Rosen H. J., Miller B. L., Ashburner J. and Gorno-Tempini M. L. (2009) Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiol. Aging 30, 103–111.
29. Brodtmann A., Cowie T., McLean C. and Darby D. (2013) Phenocopy or variant: a longitudinal study of very slowly progressive frontotemporal dementia. BMJ Case Rep. E-pub ahead of print, 2013, pii: bcr2012008077.
30. Broustal O., Camuzat A., Guillot-Noel L. et al. (2010) FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J. Alzheimers Dis. 22, 765–769.
31. Brun A. (1987) Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch. Gerontol. Geriatr. 6, 193–208.
32. Burrell J. R., Kiernan M. C., Vucic S. and Hodges J. R. (2011) Motor neuron dysfunction in frontotemporal dementia. Brain 134, 2582–2594.
33. Cacace R., Van Cauwenberghe C., Bettens K. et al. (2013) C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 34, 1712, e1711-e1717.
34. Calvo A., Moglia C., Canosa A. et al. (2012) Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene. J. Neurol. 259, 2723–2725.
35. Carecchio M., Fenoglio C., De Riz M. et al. (2009) Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease. J. Neurol. Sci. 287, 291–293.
36. Carlino E., Benedetti F., Rainero I., Asteggiano G., Cappa G., Tarenzi L., Vighetti S. and Pollo A. (2010) Pain perception and tolerance in patients with frontotemporal dementia. Pain 151, 783–789.
37. Cerami C., Marcone A., Galimberti D., Zamboni M., Fenoglio C., Serpente M., Scarpini E. and Cappa S. F. (2013) Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9. J. Alzheimers Dis. 35, 455–462.
38. Chan D., Anderson V., Pijnenburg Y. et al. (2009) The clinical profile of right temporal lobe atrophy. Brain 132, 1287–1298.
39. Chan N., Le C., Shieh P., Mozaffar T., Khare M., Bronstein J. and Kimonis V. (2012) Valosin-containing protein mutation and Parkinson's disease. Parkinsonism Relat. Disord. 18, 107–109.
40. Chare L., Hodges J. R., Leyton C. E., McGinley C., Tan R. H., Kril J. J. and Halliday G. M. (2014) New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J. Neurol. Neurosurg. Psychiatry 85, 865–870.
41. Chen Y., Zheng Z. Z., Chen X., Huang R., Yang Y., Yuan L., Pan L., Hadano S. and Shang H. F. (2014) SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 35, 726, e727-e729.
42. Chen-Plotkin A. S., Martinez-Lage M., Sleiman P. M. et al. (2011) Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch. Neurol. 68, 488–497.
43. Chio A., Calvo A., Moglia C. et al. (2010) Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. Arch. Neurol. 67, 1002–1009.
44. Chouery E., Delague V., Bergougnoux A., Koussa S., Serre J. L. and Megarbane A. (2008) Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum. Mutat. 29, E194–E204.
45. Cipolotti L. and Maguire E. A. (2003) A combined neuropsychological and neuroimaging study of topographical and non-verbal memory in semantic dementia. Neuropsychologia 41, 1148–1159.
46. Cirulli E. T., Lasseigne B. N., Petrovski S. et al. (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436–1441.
47. Clerc M. T., Deprez M., Leuba G., Lhermitte B., Lopez U. and von Gunten A. (2013) Atypical association of semantic dementia, corticobasal syndrome, and 4R tauopathy. Neurocase 21, 1–15.
48. Coccia M., Bartolini M., Luzzi S., Provinciali L. and Ralph M. A. (2004) Semantic memory is an amodal, dynamic system: evidence from the interaction of naming and object use in semantic dementia. Cogn. Neuropsychol. 21, 513–527.
49. Coon E. A., Sorenson E. J., Whitwell J. L., Knopman D. S. and Josephs K. A. (2011) Predicting survival in frontotemporal dementia with motor neuron disease. Neurology 76, 1886–1893.
50. Coon E. A., Whitwell J. L., Parisi J. E., Dickson D. W. and Josephs K. A. (2012) Right temporal variant frontotemporal dementia with motor neuron disease. J. Clin. Neurosci. 19, 85–91.
51. Cooper-Knock J., Hewitt C., Highley J. R. et al. (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135, 751–764.
52. Cooper-Knock J., Frolov A., Highley J. R. et al. (2013) C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study. Neurology 81, 808–811.
53. Corcia P., Vourc'h P., Guennoc A. M., Del Mar Amador M., Blasco H., Andres C., Couratier P., Gordon P. H. and Meininger V. (2015) Pure cerebellar ataxia linked to large C9orf72 repeat expansion. Amyotroph. Lateral Scler. Frontotemporal Degener. 17, 301–303.
54. Cox L. E., Ferraiuolo L., Goodall E. F. et al. (2010) Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5, e9872.
55. Cruchaga C., Graff C., Chiang H. H. et al. (2011) Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch. Neurol. 68, 581–586.
56. Cruts M., Gijselinck I., van der Zee J. et al. (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920–924.
57. Cruts M., Theuns J. and Van Broeckhoven C. (2012) Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 33, 1340–1344.
58. Cuyvers E., Bettens K., Philtjens S. et al. (2014) Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol. Aging 35, 726, e711-e729.
59. Davies R. R., Kipps C. M., Mitchell J., Kril J. J., Halliday G. M. and Hodges J. R. (2006) Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch. Neurol. 63, 1627–1631.
60. DeJesus-Hernandez M., Mackenzie I. R., Boeve B. F. et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245–256.
61. Deng H. X., Chen W., Hong S. T. et al. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211–215.
62. Devenney E., Hornberger M., Irish M., Mioshi E., Burrell J., Tan R., Kiernan M. C. and Hodges J. R. (2014) Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 71, 331–339.
63. Devenney E., Vucic S., Hodges J. R. and Kiernan M. C. (2015) Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev. Neurother. 15, 509–522.
64. Di Fabio R., Tessa A., Simons E. J., Santorelli F. M., Casali C., Serrao M., Pierelli F. and Bonifati V. (2010) Familial frontotemporal dementia with parkinsonism associated with the progranulin c.C1021T (p. Q341X) mutation. Parkinsonism Relat. Disord. 16, 484–485.
65. Di Fonzo A., Ronchi D., Gallia F. et al. (2014) Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation. Neurology 82, 1990–1998.
66. Dobson-Stone C., Hallupp M., Bartley L., Shepherd C. E., Halliday G. M., Schofield P. R., Hodges J. R. and Kwok J. B. (2012) C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 79, 995–1001.
67. Downey L. E., Fletcher P. D., Golden H. L. et al. (2014) Altered body schema processing in frontotemporal dementia with C9ORF72 mutations. J. Neurol. Neurosurg. Psychiatry 85, 1016–1023.
68. Duffy J. R. (2006) Apraxia of speech in degenerative neurologic disease. Aphasiology 20, 511–527.
69. Edwards-Lee T., Miller B. L., Benson D. F., Cummings J. L., Russell G. L., Boone K. and Mena I. (1997) The temporal variant of frontotemporal dementia. Brain 120(Pt 6), 1027–1040.
70. Englund E., Gustafson L., Passant U., Majounie E., Renton A. E., Traynor B. J., Rohrer J. D., Mok K. and Hardy J. (2012) Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. Neurobiol. Aging 33, 1850, e1813-e1856.
71. Escourolle R. (1958) La maladie de Pick. Etude critique d'ensemble et synthèse anatomo-clinique. R. Foulon, Paris.
72. Espay A. J. and Litvan I. (2011) Parkinsonism and frontotemporal dementia: the clinical overlap. J. Mol. Neurosci. 45, 343–349.
73. Evans J. J., Heggs A. J., Antoun N. and Hodges J. R. (1995) Progressive prosopagnosia associated with selective right temporal lobe atrophy. A new syndrome?. Brain, 118 (Pt 1), 1–13.
74. Fecto F., Yan J., Vemula S. P. et al. (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440–1446.
75. Fernandez-Duque D. and Black S. E. (2005) Impaired recognition of negative facial emotions in patients with frontotemporal dementia. Neuropsychologia 43, 1673–1687.
76. Finch N., Baker M., Crook R. et al. (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132, 583–591.
77. Finch N., Carrasquillo M. M., Baker M. et al. (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76, 467–474.
78. Fletcher P. D. and Warren J. D. (2011) Semantic dementia: a specific network-opathy. J. Mol. Neurosci. 45, 629–636.
79. Fletcher P. D., Downey L. E., Witoonpanich P. and Warren J. D. (2013) The brain basis of musicophilia: evidence from frontotemporal lobar degeneration. Front. Psychol. 4, 347.
80. Fletcher P. D., Downey L. E., Golden H. L. et al. (2015) Pain and temperature processing in dementia: a clinical and neuroanatomical analysis. Brain 138, 3360–3372.
81. Frattali C., Duffy J. R., Litvan I., Patsalides A. D. and Grafman J. (2003) Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? Eur. J. Neurol. 10, 103–106.
82. Freischmidt A., Wieland T., Richter B. et al. (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631–636.
83. Gainotti G., Barbier A. and Marra C. (2003) Slowly progressive defect in recognition of familiar people in a patient with right anterior temporal atrophy. Brain 126, 792–803.
84. Galimberti D., Fenoglio C., Serpente M. et al. (2013) Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol. Psychiatry 74, 384–391.
85. Galimberti D., Reif A., Dell'osso B. et al. (2014a) C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiol. Aging 35, 1214, e1217-1214, e1210.
86. Galimberti D., Reif A., Dell'Osso B. et al. (2014b) C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder. Bipolar Disord. 16, 448–449.
87. Gallagher M. D., Suh E., Grossman M. et al. (2014) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol. 127, 407–418.
88. Gans A. (1925) De Ziekten van Pick en van Alzheimer. Ned. Tijdschr. Geneeskd. 68, 1953.
89. Gass J., Cannon A., Mackenzie I. R. et al. (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 15, 2988–3001.
90. Gellera C., Tiloca C., Del Bo R. et al. (2013) Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 84, 183–187.
91. Gelpi E., van der Zee J., Turon Estrada A., Van Broeckhoven C. and Sanchez-Valle R. (2014) TARDBP mutation p.Ile383Val associated with semantic dementia and complex proteinopathy. Neuropathol. Appl. Neurobiol. 40, 225–230.
92. Gennari L., Gianfrancesco F., Di Stefano M. et al. (2010) SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J. Bone Miner. Res. 25, 1375–1384.
93. Gijselinck I., Van Mossevelde S., van der Zee J. et al. (2015) Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology 85, 2116–2125.
94. Giraldo M., Lopera F., Siniard A. L. et al. (2013) Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol. Aging 34, 2077, e2011-e2078.
95. Gitcho M. A., Bigio E. H., Mishra M. et al. (2009) TARDBP 3’-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol. 118, 633–645.
96. Goldman J. S., Farmer J. M., Wood E. M. et al. (2005) Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65, 1817–1819.
97. Goldman J. S., Quinzii C., Dunning-Broadbent J. et al. (2014) Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol. 71, 771–774.
98. Goll J. C., Crutch S. J., Loo J. H., Rohrer J. D., Frost C., Bamiou D. E. and Warren J. D. (2010) Non-verbal sound processing in the primary progressive aphasias. Brain 133, 272–285.
99. Gomez-Tortosa E., Serrano S., de Toledo M., Perez-Perez J. and Sainz M. J. (2014) Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion. Alzheimers Dement. 10, S284–S289.
100. Gordon E., Rohrer J. D., Kim L. G., Omar R., Rossor M. N., Fox N. C. and Warren J. D. (2010) Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology 74, 666–673.
101. Gorno-Tempini M. L., Dronkers N. F., Rankin K. P., Ogar J. M., Phengrasamy L., Rosen H. J., Johnson J. K., Weiner M. W. and Miller B. L. (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann. Neurol. 55, 335–346.
102. Gorno-Tempini M. L., Ogar J. M., Brambati S. M., Wang P., Jeong J. H., Rankin K. P., Dronkers N. F. and Miller B. L. (2006) Anatomical correlates of early mutism in progressive nonfluent aphasia. Neurology 67, 1849–1851.
103. Gorno-Tempini M. L., Brambati S. M., Ginex V. et al. (2008) The logopenic/phonological variant of primary progressive aphasia. Neurology 71, 1227–1234.
104. Gorno-Tempini M. L., Hillis A. E., Weintraub S. et al. (2011) Classification of primary progressive aphasia and its variants. Neurology 76, 1006–1014.
105. Graham N. L., Bak T., Patterson K. and Hodges J. R. (2003) Language function and dysfunction in corticobasal degeneration. Neurology 61, 493–499.
106. Graham A., Davies R., Xuereb J., Halliday G., Kril J., Creasey H., Graham K. and Hodges J. (2005) Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 128, 597–605.
107. Grossman M. and Moore P. (2005) A longitudinal study of sentence comprehension difficulty in primary progressive aphasia. J. Neurol. Neurosurg. Psychiatry 76, 644–649.
108. Guerreiro R., Bilgic B., Guven G., Bras J., Rohrer J., Lohmann E., Hanagasi H., Gurvit H. and Emre M. (2013a) Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family. Neurobiol. Aging 34, 2890, e2891-e2895.
109. Guerreiro R., Wojtas A., Bras J. et al. (2013b) TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117–127.
110. Guerreiro R. J., Lohmann E., Bras J. M. et al. (2013c) Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 70, 78–84.
111. Gydesen S., Brown J. M., Brun A. et al. (2002) Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59, 1585–1594.
112. Harris J. M., Gall C., Thompson J. C. et al. (2013a) Classification and pathology of primary progressive aphasia. Neurology 81, 1832–1839.
113. Harris J. M., Gall C., Thompson J. C. et al. (2013b) Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia. Neurology 80, 1881–1887.
114. Hensman Moss D. J., Poulter M., Beck J. et al. (2014) C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82, 292–299.
115. Hirano M., Nakamura Y., Saigoh K., Sakamoto H., Ueno S., Isono C., Mitsui Y. and Kusunoki S. (2015) VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Neurobiol. Aging 36, 1604, e1601-e1606.
116. Hodges J. R. and Patterson K. (2007) Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol. 6, 1004–1014.
117. Hodges J. R., Patterson K., Oxbury S. and Funnell E. (1992) Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain, 115 (Pt 6), 1783–1806.
118. Hodges J. R., Davies R. R., Xuereb J. H., Casey B., Broe M., Bak T. H., Kril J. J. and Halliday G. M. (2004) Clinicopathological correlates in frontotemporal dementia. Ann. Neurol. 56, 399–406.
119. Hodges J. R., Mitchell J., Dawson K., Spillantini M. G., Xuereb J. H., McMonagle P., Nestor P. J. and Patterson K. (2010) Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 133, 300–306.
120. Holm I. E., Isaacs A. M. and Mackenzie I. R. (2009) Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol. 118, 719–720.
121. Hornberger M., Piguet O., Kipps C. and Hodges J. R. (2008) Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia. Neurology 71, 1481–1488.
122. Hornberger M., Shelley B. P., Kipps C. M., Piguet O. and Hodges J. R. (2009) Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation? J. Neurol. Neurosurg. Psychiatry 80, 591–593.
123. Hsieh S., Hodges J. R., Leyton C. E. and Mioshi E. (2012) Longitudinal changes in primary progressive aphasias: differences in cognitive and dementia staging measures. Dement. Geriatr. Cogn. Disord. 34, 135–141.
124. Hsiung G. Y., DeJesus-Hernandez M., Feldman H. H. et al. (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135, 709–722.
125. Huey E. D., Ferrari R., Moreno J. H. et al. (2012) FUS and TDP43 genetic variability in FTD and CBS. Neurobiol. Aging 33, 1016, e1019-1017.
126. Hutton M., Lendon C. L., Rizzu P. et al. (1998) Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705.
127. Irish M., Devenney E., Wong S., Dobson-Stone C., Kwok J. B., Piguet O., Hodges J. R. and Hornberger M. (2013) Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions. Neuroimage Clin. 2, 836–843.
128. Ishizuka T., Nakamura M., Ichiba M. and Sano A. (2011) Familial semantic dementia with P301L mutation in the Tau gene. Dement. Geriatr. Cogn. Disord. 31, 334–340.
129. Johnson J. K., Diehl J., Mendez M. F. et al. (2005) Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch. Neurol. 62, 925–930.
130. Jonsson T., Stefansson H., Steinberg S. et al. (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107–116.
131. Josephs K. A. and Duffy J. R. (2008) Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr. Opin. Neurol. 21, 688–692.
132. Josephs K. A., Boeve B. F., Duffy J. R., Smith G. E., Knopman D. S., Parisi J. E., Petersen R. C. and Dickson D. W. (2005) Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11, 283–296.
133. Josephs K. A., Duffy J. R., Strand E. A. et al. (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129, 1385–1398.
134. Josephs K. A., Duffy J. R., Strand E. A., Machulda M. M., Senjem M. L., Master A. V., Lowe V. J., Jack C. R., Jr and Whitwell J. L. (2012) Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 135, 1522–1536.
135. Josephs K. A., Whitwell J. L., Murray M. E. et al. (2013) Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain 136, 455–470.
136. Josephs K. A., Duffy J. R., Strand E. A. et al. (2014) The evolution of primary progressive apraxia of speech. Brain 137, 2783–2795.
137. Joubert S., Felician O., Barbeau E., Ranjeva J. P., Christophe M., Didic M., Poncet M. and Ceccaldi M. (2006) The right temporal lobe variant of frontotemporal dementia: cognitive and neuroanatomical profile of three patients. J. Neurol. 253, 1447–1458.
138. Kabashi E., Valdmanis P. N., Dion P. et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572–574.
139. Kamminga J., Kumfor F., Burrell J. R., Piguet O., Hodges J. R. and Irish M. (2015) Differentiating between right-lateralised semantic dementia and behavioural-variant frontotemporal dementia: an examination of clinical characteristics and emotion processing. J. Neurol. Neurosurg. Psychiatry 86, 1082–1088.
140. Kelley B. J., Haidar W., Boeve B. F. et al. (2009) Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol. Aging 30, 739–751.
141. Kertesz A., Davidson W., McCabe P., Takagi K. and Munoz D. (2003) Primary progressive aphasia: diagnosis, varieties, evolution. J. Int. Neuropsychol. Soc. 9, 710–719.
142. Kertesz A., McMonagle P. and Jesso S. (2011) Extrapyramidal syndromes in frontotemporal degeneration. J. Mol. Neurosci. 45, 336–342.
143. Kertesz A., Ang L. C., Jesso S., MacKinley J., Baker M., Brown P., Shoesmith C., Rademakers R. and Finger E. C. (2013) Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cogn. Behav. Neurol. 26, 146–154.
144. Khan B. K., Yokoyama J. S., Takada L. T. et al. (2012) Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J. Neurol. Neurosurg. Psychiatry 83, 358–364.
145. Kim E. J., Park Y. E., Kim D. S. et al. (2011) Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family. Arch. Neurol. 68, 787–796.
146. Kipps C. M., Hodges J. R., Fryer T. D. and Nestor P. J. (2009a) Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain 132, 2566–2578.
147. Kipps C. M., Nestor P. J., Acosta-Cabronero J., Arnold R. and Hodges J. R. (2009b) Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing. Brain 132, 592–603.
148. Kouri N., Carlomagno Y., Baker M. et al. (2014) Novel mutation in MAPT exon 13 (p. N410H) causes corticobasal degeneration. Acta Neuropathol. 127, 271–282.
149. Kovacs G. G., Murrell J. R., Horvath S., Haraszti L., Majtenyi K., Molnar M. J., Budka H., Ghetti B. and Spina S. (2009) TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 24, 1843–1847.
150. Kremen S. A., Mendez M. F., Tsai P. H. and Teng E. (2011) Extrapyramidal signs in the primary progressive aphasias. Am. J. Alzheimers Dis. Other Demen. 26, 72–77.
151. Kumfor F. and Piguet O. (2012) Disturbance of emotion processing in frontotemporal dementia: a synthesis of cognitive and neuroimaging findings. Neuropsychol. Rev. 22, 280–297.
152. Kwiatkowski T. J., Jr, Bosco D. A., Leclerc A. L. et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205–1208.
153. Lanata S. C. and Miller B. L. (2015) The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry. J. Neurol. Neurosurg. Psychiatry 87, 501–11.
154. Lashley T., Rohrer J. D., Mahoney C., Gordon E., Beck J., Mead S., Warren J., Rossor M. and Revesz T. (2014) A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia. Neuropathol. Appl. Neurobiol. 40, 502–513.
155. Lashley T., Rohrer J. D., Mead S. and Revesz T. (2015) Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol. Appl. Neurobiol. 41, 858–881.
156. Lattante S., Le Ber I., Camuzat A. et al. (2013) TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia. Neurobiol. Aging 34, 2443, e2441-e2442.
157. Lavenu I., Pasquier F., Lebert F., Petit H. and Van der Linden M. (1999) Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 13, 96–101.
158. Le Ber I. (2013) Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm. Rev. Neurol. (Paris) 169, 811–819.
159. Le Ber I., Camuzat A., Hannequin D. et al. (2008) Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 131, 732–746.
160. Le Ber I., Camuzat A., Guerreiro R. et al. (2013) SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 70, 1403–1410.
161. Le Ber I., De Septenville A., Guerreiro R. et al. (2014) Homozygous TREM2 mutation in a family with atypical frontotemporal dementia. Neurobiol. Aging 35, 2419, e2423-2415.
162. Le Ber I., De Septenville A., Millecamps S. et al. (2015) TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts. Neurobiol. Aging 36, 3116, e3115-e3118.
163. Lesage S., Le Ber I., Condroyer C. et al. (2013) C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain 136, 385–391.
164. Lill C. M., Rengmark A., Pihlstrom L. et al. (2015) The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Alzheimers Dement. 11, 1407–1416.
165. Lindquist S. G., Duno M., Batbayli M. et al. (2013) Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin. Genet. 83, 279–283.
166. Lomen-Hoerth C., Anderson T. and Miller B. (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59, 1077–1079.
167. Lough S., Kipps C. M., Treise C., Watson P., Blair J. R. and Hodges J. R. (2006) Social reasoning, emotion and empathy in frontotemporal dementia. Neuropsychologia 44, 950–958.
168. Lund and Manchester Groups (1994) Consensus Statement. Clinical and neuropathological criteria for frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 57, 416–418.
169. Mahoney C. J., Rohrer J. D., Goll J. C., Fox N. C., Rossor M. N. and Warren J. D. (2011) Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia. J. Neurol. Neurosurg. Psychiatry 82, 1274–1278.
170. Mahoney C. J., Beck J., Rohrer J. D. et al. (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135, 736–750.
171. Majounie E., Renton A. E., Mok K. et al. (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 11, 323–330.
172. Mann D., South P., Snowden J. and Neary D. (1993) Dementia of frontal lobe type: neuropathology and immunohistochemistry. J. Neurol. Neurosurg. Psychiatry 56, 605–614.
173. Marshall C. R., Guerreiro R., Thust S., Fletcher P., Rohrer J. D. and Fox N. C. (2015) A novel MAPT mutation causing corticobasal syndrome led by progressive apraxia of speech. J. Alzheimers Dis. 48, 923–926.
174. Meisler M. H., Grant A. E., Jones J. M. et al. (2013) C9ORF72 expansion in a family with bipolar disorder. Bipolar Disord. 15, 326–332.
175. Mesulam M. M. (1982) Slowly progressive aphasia without generalized dementia. Ann. Neurol. 11, 592–598.
176. Mesulam M. M. (1987) Primary progressive aphasia–differentiation from Alzheimer's disease. Ann. Neurol. 22, 533–534.
177. Mesulam M. M. (2001) Primary progressive aphasia. Ann. Neurol. 49, 425–432.
178. Mesulam M. M. (2003) Primary progressive aphasia–a language-based dementia. N. Engl. J. Med. 349, 1535–1542.
179. Mesulam M. (2013) Primary progressive aphasia: a dementia of the language network. Dement. Neuropsychol. 7, 2–9.
180. Mesulam M., Wieneke C., Rogalski E., Cobia D., Thompson C. and Weintraub S. (2009) Quantitative template for subtyping primary progressive aphasia. Arch. Neurol. 66, 1545–1551.
181. Mesulam M. M., Weintraub S., Rogalski E. J., Wieneke C., Geula C. and Bigio E. H. (2014) Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain 137, 1176–1192.
182. Millecamps S., Boillee S., Le Ber I. et al. (2012) Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 49, 258–263.
183. Miller J. W., Smith B. N., Topp S. D., Al-Chalabi A., Shaw C. E. and Vance C. (2012) Mutation analysis of VCP in British familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging 33, 2721, e2721-e2722.
184. Miller L., Rollinson S., Callister J. B. et al. (2015) p62/SQSTM1 analysis in frontotemporal lobar degeneration. Neurobiol. Aging 36, 1603, e1605-e1609.
185. Mioshi E. and Hodges J. R. (2009) Rate of change of functional abilities in frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 28, 419–426.
186. Momeni P., DeTucci K., Straub R. E., Weinberger D. R., Davies P., Grafman J., Hardy J. and Huey E. D. (2010a) Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia. Neurocase 16, 273–279.
187. Momeni P., Wickremaratchi M. M., Bell J., Arnold R., Beer R., Hardy J., Revesz T., Neal J. W. and Morris H. R. (2010b) Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin. Neurol. Neurosurg. 112, 917–920.
188. Montuschi A., Iazzolino B., Calvo A. et al. (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J. Neurol. Neurosurg. Psychiatry 86, 168–173.
189. Moreno F., Rabinovici G. D., Karydas A. et al. (2015) A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques. Acta Neuropathol Commun 3, 19.
190. Mummery C. J., Patterson K., Wise R. J., Vandenberghe R., Price C. J. and Hodges J. R. (1999) Disrupted temporal lobe connections in semantic dementia. Brain 122(Pt 1), 61–73.
191. Mummery C. J., Patterson K., Price C. J., Ashburner J., Frackowiak R. S. and Hodges J. R. (2000) A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann. Neurol. 47, 36–45.
192. Munch C., Rosenbohm A., Sperfeld A. D. et al. (2005) Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58, 777–780.
193. Munoz D. G., Ros R., Fatas M., Bermejo F. and de Yebenes J. G. (2007) Progressive nonfluent aphasia associated with a new mutation V363I in tau gene. Am. J. Alzheimers Dis. Other Demen. 22, 294–299.
194. Neary D., Snowden J. S., Gustafson L. et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546–1554.
195. Neary D., Snowden J. and Mann D. (2005) Frontotemporal dementia. Lancet Neurol. 4, 771–780.
196. Ng A. S., Rademakers R. and Miller B. L. (2015) Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann. N. Y. Acad. Sci. 1338, 71–93.
197. O'Dowd S., Curtin D., Waite A. J. et al. (2012) C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism. Mov. Disord. 27, 1072–1074.
198. Onari K. and Spatz H. (1926) Anatomische Beiträge zur Lehre von der Pickschen umschriebenen Grosshirnrinden-Atrophie (Picksche Krankheit). Z. Neurol. 101, 470–511.
199. Onyike C. U. and Diehl-Schmid J. (2013) The epidemiology of frontotemporal dementia. Int. Rev. Psychiatry 25, 130–137.
200. Origone P., Verdiani S., Ciotti P., Gulli R., Bellone E., Marchese R., Abbruzzese G. and Mandich P. (2013) Enlarging the clinical spectrum associated with C9orf 72 repeat expansions: findings in an Italian cohort of patients with parkinsonian syndromes and relevance for genetic counselling. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 479–480.
201. Paloneva J., Kestila M., Wu J. et al. (2000) Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25, 357–361.
202. Park H. K. and Chung S. J. (2013) New perspective on parkinsonism in frontotemporal lobar degeneration. J. Mov. Dis. 6, 1–8.
203. Parkinson N., Ince P. G., Smith M. O. et al. (2006) ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67, 1074–1077.
204. Pick A. (1892) Über die Beziehungen der senilen Hirnatrophie zur Aphasie. Prager Med Wochenschr 17, 165–167.
205. Pickering-Brown S. M., Rollinson S., Du Plessis D., Morrison K. E., Varma A., Richardson A. M., Neary D., Snowden J. S. and Mann D. M. (2008) Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 131, 721–731.
206. Piguet O., Halliday G. M., Creasey H., Broe G. A. and Kril J. J. (2009) Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease. Int. Psychogeriatr. 21, 688–695.
207. Piwnica-Worms K. E., Omar R., Hailstone J. C. and Warren J. D. (2010) Flavour processing in semantic dementia. Cortex 46, 761–768.
208. Pottier C., Wallon D., Rousseau S., Rovelet-Lecrux A., Richard A. C., Rollin-Sillaire A., Frebourg T., Campion D. and Hannequin D. (2013) TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J. Alzheimers Dis. 35, 45–49.
209. Pottier C., Bieniek K. F., Finch N. et al. (2015) Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130, 77–92.
210. Rami L., Loy C. T., Hailstone J. and Warren J. D. (2007) Odour identification in frontotemporal lobar degeneration. J. Neurol. 254, 431–435.
211. Rascovsky K., Hodges J. R., Knopman D. et al. (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477.
212. Rayaprolu S., Mullen B., Baker M. et al. (2013) TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 8, 19.
213. Renton A. E., Majounie E., Waite A. et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257–268.
214. Robinson A., Davidson Y., Snowden J. S. and Mann D. M. (2014) C9ORF72 in dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry 85, 1435–1436.
215. Rohrer J. D. and Warren J. D. (2011) Phenotypic signatures of genetic frontotemporal dementia. Curr. Opin. Neurol. 24, 542–549.
216. Rohrer J. D., Knight W. D., Warren J. E., Fox N. C., Rossor M. N. and Warren J. D. (2008) Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain 131, 8–38.
217. Rohrer J. D., Guerreiro R., Vandrovcova J. et al. (2009a) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73, 1451–1456.
218. Rohrer J. D., Warren J. D., Modat M., Ridgway G. R., Douiri A., Rossor M. N., Ourselin S. and Fox N. C. (2009b) Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 72, 1562–1569.
219. Rohrer J. D., Crutch S. J., Warrington E. K. and Warren J. D. (2010a) Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia 48, 288–297.
220. Rohrer J. D., Paviour D., Bronstein A. M., O'Sullivan S. S., Lees A. and Warren J. D. (2010b) Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov. Disord. 25, 179–188.
221. Rohrer J. D., Rossor M. N. and Warren J. D. (2010c) Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis. Neurology 75, 603–610.
222. Rohrer J. D., Lashley T., Schott J. M. et al. (2011a) Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134, 2565–2581.
223. Rohrer J. D., Paviour D., Vandrovcova J., Hodges J., de Silva R. and Rossor M. N. (2011b) Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome. Neurodegener. Dis. 8, 149–152.
224. Rohrer J. D., Rossor M. N. and Warren J. D. (2012) Alzheimer's pathology in primary progressive aphasia. Neurobiol. Aging 33, 744–752.
225. Rohrer J. D., Caso F., Mahoney C. et al. (2013a) Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia. Brain Lang. 127, 121–126.
226. Rohrer J. D., Warren J. D., Fox N. C. and Rossor M. N. (2013b) Presymptomatic studies in genetic frontotemporal dementia. Rev. Neurol. (Paris) 169, 820–824.
227. Rohrer J. D., Isaacs A. M., Mizielinska S. et al. (2015a) C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 14, 291–301.
228. Rohrer J. D., Nicholas J. M., Cash D. M. et al. (2015b) Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 14, 253–262.
229. Rosen H. J., Pace-Savitsky K., Perry R. J., Kramer J. H., Miller B. L. and Levenson R. W. (2004) Recognition of emotion in the frontal and temporal variants of frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 17, 277–281.
230. Rosen H. J., Allison S. C., Ogar J. M., Amici S., Rose K., Dronkers N., Miller B. L. and Gorno-Tempini M. L. (2006) Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 67, 1752–1756.
231. Rossi G., Marelli C., Farina L., Laura M., Maria Basile A., Ciano C., Tagliavini F. and Pareyson D. (2008) The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov. Disord. 23, 892–895.
232. Rossi G., Bastone A., Piccoli E. et al. (2014) Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features. Neurobiol. Aging 35, 408–417.
233. Rubino E., Rainero I., Chio A. et al. (2012) SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79, 1556–1562.
234. Ruiz A., Dols-Icardo O., Bullido M. J. et al. (2014) Assessing the role of the TREM2 p. R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Neurobiol. Aging 35, 444, e441-e444.
235. Rutherford N. J., Zhang Y. J., Baker M. et al. (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 4, e1000193.
236. Sajjadi S. A., Patterson K., Arnold R. J., Watson P. C. and Nestor P. J. (2012) Primary progressive aphasia: a tale of two syndromes and the rest. Neurology 78, 1670–1677.
237. Sajjadi S. A., Patterson K. and Nestor P. J. (2014) Logopenic, mixed, or Alzheimer-related aphasia? Neurology 82, 1127–1131.
238. Scahill R. I., Schott J. M., Stevens J. M., Rossor M. N. and Fox N. C. (2002) Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc. Natl Acad. Sci. USA 99, 4703–4707.
239. Seelaar H., Kamphorst W., Rosso S. M. et al. (2008) Distinct genetic forms of frontotemporal dementia. Neurology 71, 1220–1226.
240. Seelaar H., Rohrer J. D., Pijnenburg Y. A., Fox N. C. and van Swieten J. C. (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J. Neurol. Neurosurg. Psychiatry 82, 476–486.
241. Seeley W. W., Bauer A. M., Miller B. L., Gorno-Tempini M. L., Kramer J. H., Weiner M. and Rosen H. J. (2005) The natural history of temporal variant frontotemporal dementia. Neurology 64, 1384–1390.
242. Seeley W. W., Matthews B. R., Crawford R. K., Gorno-Tempini M. L., Foti D., Mackenzie I. R. and Miller B. L. (2008) Unravelling Bolero: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain 131, 39–49.
243. Simon-Sanchez J., Dopper E. G., Cohn-Hokke P. E. et al. (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135, 723–735.
244. Siuda J., Fujioka S. and Wszolek Z. K. (2014) Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat. Disord. 20, 957–964.
245. Skibinski G., Parkinson N. J., Brown J. M. et al. (2005) Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806–808.
246. Slattery C. F., Beck J. A., Harper L. et al. (2014) R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Alzheimers Dement. 10, 602–608, e604.
247. Snowden J. S. and Neary D. (1993) Progressive language dysfunction and lobar atrophy. Dementia 4, 226–231.
248. Snowden J. S., Goulding P. and Neary D. (1989) Semantic dementia: a form of circumscribed cerebral atrophy. Behav. Neurol. 115, 1783–1806.
249. Snowden J. S., Bathgate D., Varma A., Blackshaw A., Gibbons Z. C. and Neary D. (2001) Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J. Neurol. Neurosurg. Psychiatry 70, 323–332.
250. Snowden J. S., Rollinson S., Thompson J. C. et al. (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135, 693–708.
251. Snowden J. S., Harris J., Richardson A., Rollinson S., Thompson J. C., Neary D., Mann D. M. and Pickering-Brown S. (2013) Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 172–176.
252. Snowden J. S., Adams J., Harris J. et al. (2015) Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 497–505.
253. Spina S., Van Laar A. D., Murrell J. R. et al. (2013) Phenotypic variability in three families with valosin-containing protein mutation. Eur. J. Neurol. 20, 251–258.
254. Sreedharan J., Blair I. P., Tripathi V. B. et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668–1672.
255. Stokholm J., Teasdale T. W., Johannsen P., Nielsen J. E., Nielsen T. T., Isaacs A., Brown J. M. and Gade A. (2013) Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study. J. Neurol. Neurosurg. Psychiatry 84, 170–176.
256. Strong M. J., Grace G. M., Freedman M., Lomen-Hoerth C., Woolley S., Goldstein L. H., Murphy J., Shoesmith C., Rosenfeld J., Leigh P. N., Bruijn L., Ince P. and Figlewicz D. (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 10, 131–46.
257. Sturm V. E., McCarthy M. E., Yun I. et al. (2011) Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples. Soc. Cogn. Affect. Neurosci. 6, 359–367.
258. Suhonen N. M., Kaivorinne A. L., Moilanen V., Bode M., Takalo R., Hanninen T. and Remes A. M. (2014) Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study. Neurocase 21, 85–89.
259. van Swieten J. C. and Heutink P. (2008) Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 7, 965–974.
260. van Swieten J. and Spillantini M. G. (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 17, 63–73.
261. Synofzik M., Maetzler W., Grehl T. et al. (2012) Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Neurobiol. Aging 33, 2949, e2913-e2947.
262. Synofzik M., Born C., Rominger A. et al. (2014) Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease. Neurobiol. Aging 35, 1212, e1211-e1215.
263. Tabrizi S. J., Langbehn D. R., Leavitt B. R. et al. (2009) Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 8, 791–801.
264. Taylor L. J., Brown R. G., Tsermentseli S., Al-Chalabi A., Shaw C. E., Ellis C. M., Leigh P. N. and Goldstein L. H. (2012) Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J. Neurol. Neurosurg. Psychiatry 84, 494–498.
265. Thelen M., Razquin C., Hernandez I. et al. (2014) Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes. Neurobiol. Aging 35, 2657, e2613-e2659.
266. Thompson S. A., Patterson K. and Hodges J. R. (2003) Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology 61, 1196–1203.
267. Ticozzi N., Silani V., LeClerc A. L. et al. (2009) Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 73, 1180–1185.
268. Tolboom N., Koedam E. L., Schott J. M. et al. (2010) Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings. Alzheimer Dis. Assoc. Disord. 24, 303–307.
269. Tsuboi Y., Baker M., Hutton M. L. et al. (2002) Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology 59, 1791–1793.
270. Tyrrell P. J., Warrington E. K., Frackowiak R. S. and Rossor M. N. (1990) Progressive degeneration of the right temporal lobe studied with positron emission tomography. J. Neurol. Neurosurg. Psychiatry 53, 1046–1050.
271. Tyrrell P. J., Kartsounis L. D., Frackowiak R. S., Findley L. J. and Rossor M. N. (1991) Progressive loss of speech output and orofacial dyspraxia associated with frontal lobe hypometabolism. J. Neurol. Neurosurg. Psychiatry 54, 351–357.
272. Van Deerlin V. M., Leverenz J. B., Bekris L. M. et al. (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7, 409–416.
273. Van Langenhove T., van der Zee J., Sleegers K. et al. (2010) Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74, 366–371.
274. Van Mossevelde S., der van Zee J., Gijselinck I. et al. (2016) Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain 139, 452–467.
275. Vance C., Rogelj B., Hortobagyi T. et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208–1211.
276. Velakoulis D., Walterfang M., Mocellin R., Pantelis C. and McLean C. (2009) Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br. J. Psychiatry 194, 298–305.
277. Villa C., Ghezzi L., Pietroboni A. M. et al. (2011) A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia. J. Alzheimers Dis. 26, 19–26.
278. Wallon D., Rovelet-Lecrux A., Deramecourt V. et al. (2012) Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. J. Alzheimers Dis. 32, 19–22.
279. Warren J. D. and Rohrer J. D. (2009) Ravel's last illness: a unifying hypothesis. Brain 132, e114.
280. Warren J. D., Rohrer J. D. and Rossor M. N. (2013) Clinical review. Frontotemporal dementia. BMJ 347, f4827.
281. Warrington E. K. (1975) The selective impairment of semantic memory. Q. J. Exp. Psychol. 27, 635–657.
282. Watts G. D., Wymer J., Kovach M. J., Mehta S. G., Mumm S., Darvish D., Pestronk A., Whyte M. P. and Kimonis V. E. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377–381.
283. Whitwell J. L., Sampson E. L., Watt H. C., Harvey R. J., Rossor M. N. and Fox N. C. (2005) A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 20, 238–244.
284. Wicklund M. R., Duffy J. R., Strand E. A., Machulda M. M., Whitwell J. L. and Josephs K. A. (2014) Quantitative application of the primary progressive aphasia consensus criteria. Neurology 82, 1119–1126.
285. Wilhelmsen K. C., Lynch T., Pavlou E., Higgins M. and Nygaard T. G. (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55, 1159–1165.
286. Wojtas A., Heggeli K. A., Finch N., Baker M., Dejesus-Hernandez M., Younkin S. G., Dickson D. W., Graff-Radford N. R. and Rademakers R. (2012) C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am. J. Neurodegener. Dis. 1, 107–118.
287. Woollacott I. O. and Mead S. (2014) The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues. Acta Neuropathol. 127, 319–332.
288. Woolley J. D., Khan B. K., Murthy N. K., Miller B. L. and Rankin K. P. (2011) The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J. Clin. Psychiatry 72, 126–133.
289. Yan J., Deng H. X., Siddique N. et al. (2010) Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 75, 807–814.
290. Zarranz J. J., Ferrer I., Lezcano E. et al. (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64, 1578–1585.
291. van der Zee J., Pirici D., Van Langenhove T. et al. (2009) Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 73, 626–632.
292. van der Zee J., Van Langenhove T., Kleinberger G. et al. (2011) TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain 134, 808–815.